|
|
By Jo Nova The TGA in Australia* have handed Clive Palmer a dynamite story to use against them and Big Pharma
Palmer is in fine form below — shining a light on the pathological success of health regulation. Early use of HCQ could have saved thousands of people, but as readers here know, if there was a cheap useful treatment for Covid available, other expensive, barely tested, risky new drugs would not be given an Emergency Use Authorization, thus threatening to kill a $200 billion dollar cash cow.
Getting rid of safe competing drugs is just a part of the business plan for Big Pharma and they would be letting down their shareholders if they didn’t lobby like hell to make it happen.
Clive Palmer paid for 37 million doses of Hydroxychloroquine (HCQ) and donated it to the Australian public.
But it arrived in Australia, it was all destroyed by the Morrison regime.
Clive Palmer also donated $1 million to fund a trial into HCQ – but the TGA shut it down and… https://t.co/0wO6UnxwKY pic.twitter.com/d1g0fIk4n4
— Craig Kelly (@CKellyUAP) March 17, 2023
….
HCQ reduced death rates by 72% in 15 early treatment trials
The short video […]
Photo: Whispyhistory
The world faced the greatest global health crisis in one hundred years, but it’s taken a whole year to write up a small study that shows hydroxychoroquine could improve the survival rate of people on ventilators by a factor of three, and that the dose matters.
If anyone says “but this is not a big study”, that’s exactly my point. Why is it so hard to get a large study of a drug that was already known to be useful against SARS-1 fifteen years before SARS-2 arrived. A drug that even the President of the US was talking about in the earliest days? In January 2020 we already knew that the three drugs that were “fairly effective” were Remdesivir, Chloroquine and Ritonavir. On February 13, the South Koreans were already recommending hydroxychloroquine and telling us the anti-virals should be “started as soon as possible”. We had that head start, we threw it away.
Apparently the kings-of-compassion in the commentariat would rather see deaths than admit Donald Trump was right. And the experts in Pharmaceutical Giants only cared about the profit line.
And so it comes to pass, finally, that we find out what happened to 255 […]
Who knew that Youtube was your Doctor and Guardian of Medical Truth?
Youtube banned an entire news network for one week today because they said something about one of the cheapest most commonly prescribed drugs used around the world for millions of people for long term use for the last 65 years. I don’t know what OANN said, but if someone can find that story, I’ll add a link to it, not because I agree with it (though I might) but for the sake of free speech. This move by Youtube deprives OANN of income for the next week, and heavies them to change their reporting because there is a three strikes and you’re out rule. It also deprives potentially thousands of people for hearing a different point of view. Thus Youtube is even more powerful than any appointed Minister of Health — it is deciding not only what medication you should have but even what medication you might know of and potentially ask your doctor about.
YouTube temporarily suspends, demonetizes OANN
YouTube has barred One America News Network from posting new videos for a week and stripped it of its ability to make money off existing content […]
The scandal from the Swamp: Too rich to get a cheap drug?
Poor countries all over the world are using Hydroxychloroquine (HCQ) and it appears to be very useful.
The new HCQTrial suggests that despite the billion dollar budgets and expert staff, people in wealthier countries are dying from Coronavirus at far higher rates than people are in lands where HCQ is being used. And the effect of HCQ apparently holds even after researchers correct for patients being older, heavier, with higher blood pressure, living in high density apartment towers, or with getting tested more.
If word ever gets out that the Politico-Academic-Corporate-Swamp buried useful drugs because they were unprofitable and out of patent, there will be hell to pay.
The HCQTrial was done anonymously by @CovidAnalysis — who say they are PhD researchers, scientists.
You can find our research in journals like Science and Nature. For examples of why we can’t be more specific search for “raoult death threats” or “simone gold fired”. We have little interest in adding to our publication lists, being in the news, or being on TV (we have done all of these things before but feel there are more important things in […]
Good news on the HCQ front
The Henry Ford HCQ study is by no means decisive, but with death rates seemingly halved (sorta, maybe, kinda) — it does show how crazy it is to ban hydroxychloroquine. It also shows it’s low risk, and with all the conflicting studies out there, that there are a lot of ways to stuff things up.
With 10 million cases around the world it seems a bit incongruous that it’s taken so many months to get a trial this basic done with 2,000 patients. When the world only had 10,000 patients in January we already knew that the three drugs that were “fairly effective” were Remdesivir, Chloroquine and Ritonavir. As far back as February 13, the South Koreans were already recommending hydroxychloroquine and telling us the anti-virals should be “started as soon as possible.” They warned that after ten days, doctors “do not have to start antivirals”. South Korea was the experiment that worked — but we ignored it.
Speaking of slow research, the UK hydroxychloroquine trial that was stopped has restarted again as of three days ago. This is a trial to see if HCQ can prevent coronavirus in 40,000 healthcare workers.
[…]
The most popular drug with doctors all over the world will seemingly now not even be allowed in the US for Covid related treatment: HCQ No Longer Approved Even a Little for COVID-19
Molly Walker, MedPage
The FDA rescinded its emergency use authorization (EUA) of hydroxychloroquine (HCQ) to treat COVID-19 patients, citing concerns about efficacy and risks associated with its use, and saying the drug no longer meets the criteria for an EUA, the agency said on Monday.
Moreover, the FDA now says the benefits of the drug “no longer outweigh the potential risks,” citing the serious cardiac adverse events associated with the drug.
Comments underneath reveal just how contested this will be.
It’s a strange situation where patients in many poorer nations are being offered drugs that patients won’t be able to get in the richest nation in the world:
Substantial fractions of physicians treating Covid-19 patients in Europe and elsewhere report use of HCQ+AZ: 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the US, 17% in Germany, 16% in Canada, 13% in the UK (45), much of the non-US use […]
We discussed the inadequacies of the large Lancet study of hydroxychloroquine supposed used on 96,000 Covid patients from 671 hospitals. It was largely useless because it ignored zinc, wasn’t randomized and was mainly used on people who were already very ill, with a terrible 12% death rate. But it is far worse than that and has now been retracted. The number of deaths listed in Australia was higher than the official Australian tally on April 21. The number of Covid cases in Turkey was 80 times higher than official numbers.
All over the world the study spooked doctors and governments (with WHO help) into stopping the use of HCQ in their large trial across in 17 countries .That trial has since been restarted.
The authors have now retracted the paper after Surgisphere refused to transfer the full dataset “due to confidentiality”.
The Guardian investigated the company that came out of nowhere with this enormous dataset which was used in both The Lancet paper and a New England Medical Journal paper. It turned out to be small, with a handful of employees and that include a science fiction writer, an adult content model, and few scientific qualifications. When The Guardian contacted […]
A new study came out last night in the Lancet which is being used to call for the end of doctors using Choloroquine and Hydroxychloroquine to treat Covid patients without them being enrolled in a clinical trial. Some of the claims about “no chance of any benefit” seem a bit premature given the limits of this kind of study:
Superficially, it looks large and comprehensive but there are three obvious problems with it —
1. It ignores zinc entirely. There is not even a mention of the essential mineral, despite Chloroquine being a well known zinc ionophone (something that pumps a mineral across a cell membrane) and intracellular zinc being identified as a useful anti-viral.
2. It’s not randomized. If doctors are prescribing these drugs to sicker patients or patients with a certain (unknown) genetic risk factor that selection bias (there we go again) could neutralize the entire result. We just don’t know.
3. These were sick people. The total mortality in this whole group was almost 12%. This trial tells us nothing about using these drugs as preventative measures in mild or moderate cases. It doesn’t tell us whether people had symptoms for […]
A High Stakes Game
If the trials of the anti-malarial chloroquine (or variants) work, Trump will get away with all the understatements he said in February.
On twitter the combination of Hydroxychloroquine and azithromycin are known as #TrumpPills. The trials started Tuesday. We don’t know the results but doctors are buying up pharmacy stocks across the US — presumably to protect themselves (hopefully).
As the death tolls mounts, the Democrats are surely planning to put all the Trump quotes like “it’s going to disappear. One day, it’s like a miracle” on high rotation leading up to the election. But if the trials of anti-viral agents bring good news, he can reframe the past as if he was betting on that in February. (Perhaps he was?)
Though not many people spend two trillion dollars on a problem that’s disappearing.
Combo of existing drugs shows promise against COVID-19
Most patients treated with hydroxychloroquine alone cleared the virus in three to six days, compared to an average of 20 in China — …
The authors advise: “Use this treatment cocktail early, and don’t wait until a patient is on a ventilator in the intensive-care unit.” They also note that […]
I’ve said from the start that anti-virals were always going to be more useful to us this year than vaccines, which take so long to test and be ready for use. What we really need are anti-virals which also happen to be preapproved and tested and hopefully in mass production. Chloroquine is cheap too, though I doubt Australian stocks of the drug are very high, or that our genius rulers have arranged more. This may be a godsend in Africa where chloroquine use is already high and may reduce the spread of Covid-19 somewhat.
The UK banned export of chloroquine a few weeks ago. Clearly someone there thought it might be useful.
Wang et al reported on Feb 4th that Chloroquine (anti-Malarial) and Remdesivir (anti HIV) may be useful against Coronavirus. They used lab experiments on cells in glass, which had promise. But “in vitro” doesn’t always mean “in vivo”. So I’ve been waiting for some results on people. Early reports were ambiguous. Recently this was hyped as an “Australian cure” which really just meant the start of a proper trial.
There are links to papers and discussion below but I can’t beat this great description explaining how inside the […]
|
JoNova A science presenter, writer, speaker & former TV host; author of The Skeptic's Handbook (over 200,000 copies distributed & available in 15 languages).
Jo appreciates your support to help her keep doing what she does. This blog is funded by donations. Thanks!
Follow Jo's Tweets To report "lost" comments or defamatory and offensive remarks, email the moderators at: support.jonova AT proton.me
Statistics
The nerds have the numbers on precious metals investments on the ASX
|
Recent Comments